Insulet Corp
(STU:GOV)
€
228.1
5 (2.24%)
Market Cap: 17.41 Bil
Enterprise Value: 17.87 Bil
PE Ratio: 45.89
PB Ratio: 16.81
GF Score: 93/100 Insulet Corp at Robert W Baird Global Healthcare Conference (Virtual) Transcript
Sep 15, 2021 / 06:00PM GMT
Release Date Price:
€246.2
(-0.24%)
Jeffrey D. Johnson
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
All right. Good afternoon. I think we're all here now. So why don't we get started? My name is Jeff Johnson. I'm the senior medical technology analyst at Baird. And our next presentation this afternoon is from Insulet, a leader in the $3 billion global insulin pump market. With us today from Insulet, we're happy to have Chief Commercial Officer Bret Christensen; and VP of Investor Relations, Deb Gordon.
Bret, I think we'll just go into Q&A -- straight into Q&A, unless you have any fantastic overview you want to provide.
Bret Christensen
Insulet Corporation - Executive VP & Chief Commercial Officer
No. Jeff, thanks for having us. It's great to be here. I'm excited to talk about the business.
Questions & Answers
Jeffrey D. Johnson
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
Good. Good. Well, let's just jump right in. I want to talk -- I know
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot